Mizoribine therapy combined with steroids and mizoribine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome

2017
Background We designed a prospective and randomized trial of mizoribine(MZR) therapy combined with prednisolone( PSL) for idiopathic membranous nephropathy(IMN) with steroid-resistant nephrotic syndrome(SRNS).
    • Correction
    • Source
    • Cite
    • Save
    36
    References
    7
    Citations
    NaN
    KQI
    []
    Baidu
    map